Prenetics Global Limited (NASDAQ:PRENW) Sees Large Increase in Short Interest

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 9,137 shares, an increase of 171.9% from the April 30th total of 3,360 shares. Based on an average daily trading volume, of 6,546 shares, the days-to-cover ratio is currently 1.4 days.

Prenetics Global Stock Performance

Shares of PRENW traded down $0.00 during mid-day trading on Friday, hitting $0.01. The stock had a trading volume of 17,735 shares, compared to its average volume of 17,165. The business has a fifty day moving average price of $0.02 and a 200-day moving average price of $0.02. Prenetics Global has a 52 week low of $0.01 and a 52 week high of $0.07.

Prenetics Global Company Profile

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.